BackNxera Pharma , Ltd. Overview

Nxera Pharma , Ltd. Total Liabilities

Nxera Pharma , Ltd.'s total liabilities is $67B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$67.09B
↓ 14.89% YoYΔ $-11.74B vs prior year quarter

Peer trimmed avg / median

Loading

Nxera Pharma , Ltd. Total Liabilities History

Loading

Nxera Pharma , Ltd. vs. peers: Total Liabilities Comparison

Loading

Nxera Pharma , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nxera Pharma , Ltd. (SOLTF) FAQ

Nxera Pharma , Ltd. (SOLTF) currently reports a total liabilities of $67B as of June 2026. That compares with $79B in the prior-year period — down 14.9% year over year. Use the charts on this page to explore Nxera Pharma , Ltd.'s total liabilities history and peer comparisons.

Nxera Pharma , Ltd.'s total liabilities decreased from $79B to $67B — a 14.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nxera Pharma , Ltd. reported $67B in total liabilities as of June 2026. That compares with $79B in the prior-year period — down 14.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $67B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nxera Pharma , Ltd., and consider following SOLTF for alerts when major investors trade the stock.

Nxera Pharma , Ltd. is classified in the Healthcare sector. On total liabilities, it currently shows $67B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SOLTF with unrelated industries.